HLA-G and COVID-19: Moreover, higher levels of sHLA-G are associated with increased expression of sICAM-1 and sE-selectin expression, which may contribute to improved clinical conditions in COVID-19 patients by reducing neutrophil adhesion to activated endothelium (56).